INTRODUCTION
============

Stevens-Johnson syndrome (SJS) is an acute, self-limiting disorder that affects the skin and two or more mucosal membranes. SJS is frequently accompanied by systemic involvement and can be lethal in certain cases. Although its incidence is low, SJS is life threatening, and its mortality is estimated at 5%. Despite certain idiopathic cases, SJS is usually triggered by medications or associated with an infectious process ([@b1-cln_69p168]-[@b3-cln_69p168]). Acute and chronic ocular complications of SJS can be severe, involving the conjunctiva, the eyelids, and the cornea ([@b1-cln_69p168]-[@b3-cln_69p168]).

The normal microbial flora of the eyelids and conjunctiva is composed of a heterogeneous bacterial assemblage that is controlled by intrinsic mechanisms (nutrient competition, metabolic inhibition, and enzyme production) and by host mechanisms (anatomical barriers and the immunological system). Coagulase-negative *Staphylococci* (CNS), *Staphylococcus aureus*, and *Corynebacterium sp* are the most common microorganisms isolated from a healthy patient\'s conjunctiva ([@b4-cln_69p168]-[@b8-cln_69p168]).

Alteration of the conjunctival flora depends on seasonal variation, the host\'s age, and environmental exposure, as well as ocular trauma, surgical procedures, and changes in local or systemic immunity ([@b9-cln_69p168]). Topical or systemic antibiotics can also decrease the number of positive cultures ([@b4-cln_69p168],[@b6-cln_69p168],[@b7-cln_69p168]).

Nouri et al. have demonstrated that patients with SJS and cicatricial pemphigoid ocular-surface diseases are at high risk of postoperative ocular infection compared with patients with noncicatrizing corneal disease ([@b10-cln_69p168]). One of the hypotheses for this observation is that eyelid anatomical alterations (trichiasis and entropion), conjunctival cicatricial disorders (symblepharon and keratinization), corneal alterations (limbal deficiency), and severe dry eye are associated, which creates a propitious environment for the colonization of the ocular surface in these patients.

Although ocular surface alterations have been extensively studied in patients with SJS, PubMed and Medline searches with the key words "Stevens Johnson Syndrome" and "bacterial flora" revealed little information in the literature. To provide a better understanding of the components of the conjunctival flora and relevant information that can guide us in the treatment of ocular infections in patients with SJS, we performed a microbiological evaluation of inferior conjunctival scrapings, including microorganism identification and determination of antibiotic sensitivity.

MATERIALS AND METHODS
=====================

This prospective nonrandomized study consisted of sampling the inferior conjunctival eyelids of patients with SJS who were selected at the Cornea and External Ocular Diseases Clinic of the Ophthalmology Department at the Federal University of São Paulo (UNIFESP) between February and July, 2007. The protocol was approved by the Research Ethics Committee of UNIFESP. Informed consent was obtained from each subject studied. All of the experiments in this study followed the tenets of the Declaration of Helsinki.

The patients were submitted to ophthalmological examination, and information regarding gender, age, the duration of disease, the probable cause of SJS, previous surgical treatments, and current clinical treatment were collected.

After an initial evaluation, the patients received nonpreserved 0.5% methylcellulose eye drops (Ophthalmos, SP, Brazil) for use q.i.d. for 2 weeks, up to the sampling day. Any other types of eye drops and systemic antibiotics, anti-inflammatories, and antifungals were discontinued for this period. Patients with a current diagnosis of any ocular or systemic infection or with a history of surgical procedures in the ocular region in the last 3 months were excluded from the study, as were patients who could not have their medications suspended during the study period.

Specimens were obtained with a sterile cotton swab moistened with brain-heart infusion (BHI) medium, scraping the lower conjunctival sac and inferior tarsal without touching the eyelid margins or cilia, during slit-lamp observation and without the use of any anesthetic eye drops. We repeated the same technique in the other eye.

The scrapings were performed in the same examination room, with the air conditioner turned off for 20 minutes before the standard technique procedure. The average room temperature was 20°C, and the average humidity was 70%.

The scrapings were seeded on two solid media (a blood agar plate and a chocolate agar plate) and one liquid medium (thioglycolate broth). The collected specimens were immediately spread on the solid media, incubated at 37°C, and examined daily for bacterial growth for 1 week and weekly for up to 1 month. Any transportation media were used to transport the samples to the laboratory.

Cultures showing growth of bacteria for at least two strains in any plate or changes in the color or turbidity of the broth medium were considered positive. Liquid broth specimens that were considered positive were subcultured on blood agar plates to identify the microorganism. Specimens with fungi and bacteria growing outside the seeded area were considered contaminated and were thus discarded.

Laboratory analyses consisted of culture, microorganism identification, and antimicrobial sensitivity tests. The isolated microorganisms were submitted to sensitivity testing by the agar diffusion method using the subsequent antibiotics: amikacin, tobramycin, ceftriaxone, penicillin, gatifloxacin, sulfazotrim, gentamicin, cefalotin, chloramphenicol, polymyxin B, moxifloxacin, vancomycin, neomycin, cefoxitin, oxacillin, ciprofloxacin, and ofloxacin (adapted from CLSI M100-S20, Vol. 30, No. 1, January 2010).

RESULTS
=======

Patient description
-------------------

We evaluated 41 eyes of 22 patients, consisting of 14 females (64%) and eight males (36%) with a mean age of 33.2 years (range of 11 to 63 years) and an average disease duration of 15.6 years (range of 6 months to 55 years). Three patients had one of their eyes enucleated because of complications during disease development and were using an acrylic ocular prosthesis.

Regarding the probable causes triggering SJS, 20 patients (90%) reported drug use before the disease, and in two patients (10%), no causes were identified. The main causative drugs involved were analgesics, mainly dipyrone (eight patients), anticonvulsants (seven patients), and antibiotics such as penicillin (four patients).

The majority of the patients had been submitted to surgical procedures, including eyelid correction (seven patients), lacrimal point occlusion (five patients), penetrating keratoplasty (five patients), symblepharon correction (five patients), limbal transplant (four patients), and enucleation (three patients). Several patients were submitted to multiple surgical procedures.

Clinical treatment before the conjunctival sampling (up to 14 days before sampling) consisted of lubricants (eye drops, gel, or ointment) for every patient, vitamin A ointment for three patients and topical glucocorticoids for four patients (the majority using antibiotic-associated ointment).

The use of topical antibiotics was noted in seven patients. Chloramphenicol was being used by four patients (one alone and three as ointment combined with glucocorticoids); ofloxacin, by two patients; and ciprofloxacin, by one patient, all for prophylaxis against recurrent infections or because of contact lens (CL) use. Four patients were using CLs: two eyes with scleral lenses and the other two eyes with soft CLs. One patient had acquired immune deficiency syndrome (AIDS) and had been receiving highly active antiretroviral therapy (HAART) for 6 years, which was not suspended for this study.

The best corrected visual acuity ranged from light perception and 20/25 (average 1.57 logMar). By slit-lamp examination, corneal conjunctivalization (19 patients); limbal deficiency (18 patients); punctate keratitis (16 patients); symblepharon (10 patients); entropion, trichiasis, and occluded lacrimal points (five patients); ocular surface keratinization (four patients); tarsorrhaphy (three patients); an ocular prosthesis (three patients after enucleation); and ocular atrophy in one eye were observed. Several patients had associated ocular surface alterations.

In several patients, sampling was impaired by photophobia, restricted eyelid opening due to the coexistence of tarsorrhaphy, severe symblepharon, or pain. Despite the suspension of topical medication, none of the subjects needed drug reintroduction, and thus, we had no exclusions.

Smears and cultures
-------------------

Smears from 39 eyes (95%) yielded positive results. For the two eyes (5%) of one patient, smears were negative for the presence of bacteria.

The following bacteria were identified: gram-positive cocci (CNS, *Streptococcus sp* and *Staphylococcus aureus)* in 35 eyes (55.5%), gram-positive bacilli (*Corynebacterium sp*) in 12 eyes (19%), and gram-negative bacilli (*Enterobacter sp, Serratia nonliquefaciens, Escherichia coli, Morganella morganii, Proteus mirabilis and Haemophilus sp*) in 16 eyes (25.5%) ([Table 1](#t1-cln_69p168){ref-type="table"}).

According to microorganism association analysis, cultures showed only one species of bacterium in 18 eyes (46%) and more than one species of bacterium in 21 eyes (54%). In this last group, two bacterial species were detected in 20 eyes, and three bacterial species were identified in only one eye ([Table 2](#t2-cln_69p168){ref-type="table"}).

Positive cultures with only one species of bacterium in the conjunctiva showed gram-positive cocci in 15 eyes (38.5%), gram-positive bacilli in one eye (3%), and gram-negative bacilli in two eyes (5%). A combination of gram-positive cocci and gram-positive bacilli occurred in seven eyes (18%), and an association between gram-positive cocci and gram-negative bacilli was found in 10 eyes (25.5%). Additionally, a combination of gram-positive bacilli and gram-negative bacilli was identified in four eyes (10%) ([Table 2](#t2-cln_69p168){ref-type="table"}).

The respective conjunctival cultures of the three eyes with ocular prostheses demonstrated CNS (one eye), CNS associated with *Corynebacterium sp* (one eye), and no bacteria (one eye). One of the patients had AIDS, and his conjunctival flora showed the presence of *Staphylococcus aureus* and *Corynebacterium sp* in both eyes.

Cultured conjunctival samples from two patients with soft CLs were positive for CNS and *Corynebacterium sp.* In the two patients who were users of scleral CLs, the bacteria were *Proteus mirabilis* and CNS.

In topical glucocorticoid users (four patients), we found *Proteus mirabilis* (one patient), CNS (two patients), and CNS associated with *Streptococcus sp* (one patient).

Regarding the antibiotics used before sampling, 12 eyes of seven patients were treated with chronic antibiotic use. Chloramphenicol was being used for seven eyes; ofloxacin, for three eyes; and ciprofloxacin, for two eyes. Patient 5 (two eyes), who previously used chloramphenicol, exhibited the presence of *Proteus mirabilis* that was resistant to chloramphenicol. In patient 17 (two eyes), who used ciprofloxacin and showed the bacteria *Corynebacterium* sp and *Streptococcus sp* in culture, the *Streptococcus sp* was resistant to ciprofloxacin ([Table 3](#t3-cln_69p168){ref-type="table"}).

In the general evaluation of antimicrobial sensitivity, we divided the microorganisms into the following groups, according to level of resistance: Staphylococcus (CNS and *Staphylococcus aureus*), *Streptococcus* (*Streptococcus sp*), and gram-negative bacilli (*Enterobacter sp*, *Serratia nonliquefaciens, Escherichia coli, Morganella morganii, Proteus mirabilis,* and *Haemophilus sp*). The sensitivity of the gram-negative bacilli (including *Proteus mirabilis*) to chloramphenicol was only 33%. In the *Streptococcus* group, the sensitivity was only 50% for ciprofloxacin ([Table 4](#t4-cln_69p168){ref-type="table"}).

The *Staphylococcus* group showed high sensitivity (\>90%) to amikacin, tobramycin, ofloxacin, moxifloxacin, chloramphenicol, vancomycin, oxacillin, polymyxin, and sulfazotrim and low sensitivity (≤50%) to neomycin and penicillin ([Table 4](#t4-cln_69p168){ref-type="table"}).

The *Streptococcus* group exhibited high sensitivity (\>90%) to ofloxacin, gatifloxacin, cefalotin, and vancomycin and low sensitivity (≤50%) to amikacin, tobramycin, gentamicin, neomycin, ciprofloxacin, chloramphenicol, polymyxin B, and sulfazotrim. This group had the lowest antimicrobial sensitivity and the highest index of resistance to antibiotics ([Tables 3](#t3-cln_69p168){ref-type="table"}) and [4](#t4-cln_69p168){ref-type="table"}). In contrast, the group of gram-negative bacilli had high sensitivity (\>90%) to amikacin, gentamicin, ofloxacin, moxifloxacin, gatifloxacin, ciprofloxacin, penicillin, and polymyxin B, whereas the group had low sensitivity (≤50%) to the antibiotics ceftriaxone, cefalotin, chloramphenicol, vancomycin, and oxacillin.

DISCUSSION
==========

SJS is associated with many acute and chronic ocular complications. Patients with this illness are deficient in the ocular protection represented by tears, which prevent the entrance of pathogens and consequent infections ([@b1-cln_69p168],[@b4-cln_69p168]).

The majority of SJS carriers show acute ocular involvement, varying from light conjunctivitis to serious corneal ulcers. Chronic complications, including conjunctival scars, symblepharon, entropion, and dry eye, can lead to corneal damage, which is a determinant of vision loss ([@b1-cln_69p168],[@b3-cln_69p168]).

Different culture media can be used to isolate microorganisms from ocular samples, and the use of certain types of media at the same time can increase the possibility of detection ([@b4-cln_69p168]). In our study, we used two solid media (blood agar and chocolate agar) and one liquid medium (thioglycolate).

Several studies have demonstrated that the flora of the eyelids and conjunctiva shows a high correlation with postoperative infection. CNS is the most frequently encountered bacterium and is the most related to intraocular infections. Other microorganisms occurring in the ocular flora are *Corynebacterium sp*, which are normally found in the elderly ([@b2-cln_69p168],[@b4-cln_69p168]-[@b8-cln_69p168],[@b11-cln_69p168]-[@b15-cln_69p168]).

Thiel et al. evaluated the normal conjunctival flora of patients of varying ages and reported the following bacteria as the most frequent: *Corynebacterium sp, Megasphaera elsdenii, Bacteroides ureolyticus, Bacteroides pneumosintes,* and *Stomatococcus* ([@b13-cln_69p168]) Campos et al. demonstrated that 77.3% of normal patients were colonized by anaerobic bacteria; 63.3%, by *Propionibacterium acnes*; 13.6%, by species of *Lactobacillus*; and 15.9%, by species of *Veillonella*, without significant differences in the conjunctival flora between patients with AIDS and patients with anophthalmia ([@b9-cln_69p168]). Herde et al. studied the normal conjunctival flora of patients in the preoperative period before cataract surgery and demonstrated that the most frequent bacteria were *Staphylococcus sp* and *Proteus mirabilis* ([@b14-cln_69p168]). Hofling-Lima, analyzing bacteria isolated from the conjunctiva and eyelids of healthy patients prior to cataract and refractive surgeries in the Laboratory of Ocular Microbiology of the Escola Paulista de Medicina at UNIFESP, demonstrated that the most frequently found microorganisms were CNS, *Corynebacterium sp,* and *Staphylococcus aureus* ([@b11-cln_69p168]).

In our study, gram-positive cocci were the most common bacteria isolated, corresponding to 55.5% of the eyes. Gram-positive bacilli corresponded to 19% of the isolates, and gram-negative bacilli corresponded to 25.5%. Among all bacteria, CNS, *Corynebacterium sp*, *Staphylococcus aureus*, and *Streptococcus sp* were the main microorganisms. As for gram-negative bacilli, we found pathogenic bacteria, including *Enterobacter sp*, *Serratia nonliquefaciens, Escherichia coli, Morganella morganii, Proteus mirabilis,* and *Haemophilus sp*. The flora was formed by multiple bacteria in 54% of the eyes and by only one bacterium in 46% of the eyes. Overall, the number of associated microorganisms was much higher than in previous studies involving healthy patients.

In our SJS patients who were using CLs (soft or hard scleral), the bacteria encountered were CNS, *Proteus mirabilis,* and *Corynebacterium sp*, agreeing with the study of Erdogan et al., who demonstrated the lack of a difference between the normal conjunctival flora and the conjunctival flora of CL users ([@b16-cln_69p168]).

In our study, four eyes of two patients who were receiving chronic antibiotic treatment until 2 weeks before sample collection, two eyes treated with chloramphenicol (with positive culture for *Proteus mirabilis*), and another two eyes treated with ciprofloxacin (with positive cultures for *Streptococcus sp* and *Corynebacterium* sp) showed antimicrobial resistance to the antibiotics in use. The general sensitivity of the gram-negative bacilli to chloramphenicol was only 33%, and for the *Streptococcus* group, the sensitivity to ciprofloxacin was only 50%. We also found that the group with less sensitivity and a greater level of antimicrobial resistance included streptococci.

A high index of postoperative ocular infections is found in inflammatory conditions such as SJS and ocular cicatricial pemphigoid. Gomes et al. observed postoperative infection in 40% of patients with SJS who were submitted to ocular surface reconstruction surgery ([@b17-cln_69p168]). Another study demonstrated a high level of ocular infections in patients with SJS who were submitted to keratoprosthesis implantation ([@b10-cln_69p168]) Samson et al. reported a high incidence of infection in patients with chronic inflammatory diseases who underwent limbal stem cell transplantation ([@b18-cln_69p168]).

In summary, we characterized the conjunctival bacterial flora in patients with SJS by describing the positive cultures according to bacterial classification and antibiotic sensitivity. This study revealed a diverse conjunctival flora, including many pathogenic species, in patients with SJS. The findings provide a guide for the treatment of ocular infections in SJS and provide additional information on necessary care in the preoperative and postoperative periods, mainly regarding broad-spectrum antibiotic prophylaxis.

No potential conflict of interest was reported.

###### 

Positive cultures according to bacterial classification and number of eyes.

  GROUP                   BACTERIA                              EYES (n)   \%
  ----------------------- ------------------------------------- ---------- -------
  Gram-positive cocci     Coagulase-negative *Staphylococcus*   19         55.5
                          *Streptococcus sp*                    8          
                          *Staphylococcus aureus*               8          
  Gram-positive bacilli   *Corynebacterium sp*                  12         19.0
  Gram-negative bacilli   *Enterobacter sp*                     4          25.5
                          *Serratia nonliquefaciens*            4          
                          *Escherichia coli*                    2          
                          *Morganella morganii*                 2          
                          *Proteus mirabilis*                   2          
                          *Haemophilus sp*                      2          
  Total                                                         63 eyes    100.0

n = number of eyes.

###### 

Positive cultures isolated according to number of eyes and microorganism association.

  BACTERIA                                          EYES (n)   \%     
  ------------------------------------------------- ---------- ------ ------------------------------------------
  Only gram-positive cocci                          15         38.5   18 eyes - 46%Only one bacterium isolated
  Only gram-positive bacilli                        1          3      
  Only gram-negative bacilli                        2          5      
  Gram-positive cocci and gram-positive bacilli     7          18     21 eyes - 54%Multiple bacteria
  Gram-positive cocci and gram-negative bacilli     10         25.5   
  Gram-positive bacilli and gram-negative bacilli   4          10     
  Total                                             39 eyes    100%   100

###### 

Bacterial cultures according to previous antibiotic use and antibiotic resistance.

  Patient   Antibiotic in Use     Bacterial Culture                     Antibiotic Resistance
  --------- --------------------- ------------------------------------- -----------------------
  5         **Chloramphenicol**   *Proteus mirabilis*                   TO, CHL, NEO, OXA
  7         Chloramphenicol       *Corynebacterium*                     Not tested
                                  *Enterobacter aerogenes*              CFT
  12        Chloramphenicol       Coagulase-negative Staphylococcus     OXA, CIP
  16        Ofloxacin             *Corynebacterium*                     Not tested
                                  *Staphylococcus aureus*               GFX, GEN, OXA, CIP
  17        Ciprofloxacin         *Corynebacterium*                     Not tested
                                  *Streptococcus sp*                    GEN, **CIP**
  18        Chloramphenicol       *coagulase negative Staphylococcus*   
  22        Ofloxacin             *Corynebacterium*                     Not tested

CFT = cefalotin, OXA = oxacillin, TO = tobramycin, GEN = gentamicin, CHL = chloramphenicol, NEO = neomycin, FOX = cefoxotin, CIP = ciprofloxacin, GFX = gatifloxacin.

OBS: antibiotic abbreviations according to the Centers for Disease Control and Prevention (CDC).

###### 

Antibiotic sensitivity (%) of the bacterial groups in patients with SJS.

                             Bacterial Group                       Aminoglycoside   Fluoroquinolone   Cephalosporin   Penicillin   Sulfonamide   Other                                                                                                           
  -------------------------- ------------------------------------- ---------------- ----------------- --------------- ------------ ------------- ---------- ---------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------
  **Gram Positive-Cocci**    *Staphylococcus aureus*               100%(2)          100%(4)           75%(8)          100%(2)      75%(8)        100%(8)    75%(8)     100%(2)   100%(8)   75%(8)    100%(2)   0%(2)     100%(2)   0%(2)     100%(2)   100%(2)   100%(2)
                             Coagulase-Negative *Staphylococcus*   100%(2)          100%(2)           80%(16)         100%(2)      95%(18)       95%(18)    70%(16)    50%(4)    85%(18)   60%(18)   100%(2)   0%(2)     100%(2)   100%(2)   100%(2)   100%(2)   100%(2)
                             *Streptococcus sp*                    0%(4)            0%(4)             50%(8)          100%(4)      100%(8)       75%(8)     50%(8)     50%(4)    100%(8)   75%(8)    50%(4)              50%(4)    0%(4)     50%(4)    100%(4)   0%(4)
  **Gram-NegativeBacilli**   Gram-Negative Bacilli                 100%(6)          66%(6)            100%(16)        100%(6)      100%(16)      100%(16)   100%(16)   100%(6)   25%(16)   66%(12)   0%(6)     100%(2)   66%(6)    66%(6)    33%(6)    50%(4)    100%(6)

AK = amikacin, TO = tobramycin, GEN = gentamicin, OFL = ofloxacin, GFX = gatifloxacin, MXF = moxifloxacin, CIP = ciprofloxacin, CFR = ceftriaxone, CFT = cefalotin, FOX = cefoxotin, OXA = oxacillin, PEN = penicillin, SZT = sulfazotrim, NEO = neomycin, CHL = chloramphenicol, VAN = vancomycin, PB = polymyxin B.

( ) = number of eyes tested.

(adapted from CLSI M100-S20, Vol. 30, No. 1, January 2010).
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